Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIUMPH: Adjuvant Docetaxel/Capecitabine/Oxaliplatin in Gastric Cancer
NCT01935778Phase 3Recruiting
- Sponsor
- Asan Medical Center
- Start
- Oct 2013
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in gastric cancer (GC), sponsored by Asan Medical Center. Started Oct 2013; status: recruiting.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01935778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935778.